-+ 0.00%
-+ 0.00%
-+ 0.00%

LAKEWOOD-AMEDEX BIOTHERAPEUTICS - TOPLINE DATA FROM PHASE 2A NU-3 TRIAL EXPECTED IN Q1 2027

Reuters·09/24/2026 12:02:00

Please log in to view news